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Abstract
Accurate differentiation of focal thyroid nodules (FTL) and thyroid abnormalities is pivotal for proper diagnostic and
therapeutic work-up. In these two part articles, the role of ultrasound techniques in the characterization of FTL and evaluation
of diffuse thyroid diseases is described to expand on the recently published World Federation in Ultrasound and Medicine
(WFUMB) thyroid elastography guidelines and review how this guideline fits into a complete thyroid ultrasound exam.
Keywords: thyroid; ultrasonography; elastography; color Doppler; contrast enhanced ultrasound (CEUS); point of care (POC).

Introduction
Ultrasound (US) of the thyroid is well established
for a variety of indications and applications. US is the
most sensitive imaging test available for the examination of the thyroid gland, to detect and characterize leReceived 09.11.2016 Accepted 20.12.2016
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sions, accurately calculate their dimensions, identify
the internal structure and vascularization using color
Doppler imaging (CDI) and evaluate diffuse changes
in the thyroid parenchyma. Thyroid US is able to confirm the presence of a thyroid nodule when the physical examination is equivocal and differentiate between
thyroid nodules and cervical masses from other origins
[1,2]. In this setting, the accurate differentiation of benign from malignant lesions is critical to ensure that the
patient undergoes the appropriate diagnostic and therapeutic decision.
In the present two part papers, the role of ultrasound
techniques in the evaluation of diffuse thyroid disease
(DTD) (Part 1) and characterization of focal thyroid lesions (FTL) (Part 2) is described to accompany the recently published WFUMB thyroid elastography guide-
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lines and review how the guidelines fit into a complete
thyroid ultrasound exam.
Clinical indications according to guidelines
Thyroid ultrasound is recommended in [1,2]:
1. All patients with a palpable thyroid nodule or with
multinodular goiter.
2. High-risk patients for thyroid malignancy: history
of familial thyroid cancer, multiple endocrine neoplasia (MEN) type II and irradiated neck in childhood.
3. Patients with palpable cervical adenopathy suspicious for malignancy.
4. Follow-up and monitoring thyroid nodules.
Thyroid ultrasound is not recommended in [1,2]:
1. Patients with a normal thyroid on palpation and
low risk of thyroid cancer.
2. As a screening test in the general population.
Examination technique
The recommended protocol for thyroid US is as follows [3,4] (Table I):
1. Patient is scanned in supine position with neck extended with a small pillow or rolled towel behind
the shoulders.
2. Axial scans of the whole gland at the upper, mid,
lower poles and the isthmus, and side-by-side images of each lobe, to compare echogenicity and
size of both lobes. Each lobe width and AP diameters are measured.
3. Longitudinal scans through each lobe, on medial,
mid and lateral planes. The length of the lobes is
measured.
4. Identify focal lesions, measure the main lesions
and identify the dominant one (according to size).
5. Evaluation of vascularization using CDI of both
lobes and any lesions if detected.
6. Document the presence of enlarged lymph nodes
[5,6] or thrombosed jugular vein.
Nodules with any malignant potential (essentially all
nodules except pure cysts) should be identified [3,7].
Table I. Standardized structured US reporting criteria for thyroid evaluation.
Thyroid gland
Position
Shape
Size
Content
Echogenicity
Vascular pattern

Thyroid nodules
Size / Location
Margins
Composition (solid, cystic, spongiform,
proportion)
Presence and type of calcifications
Echogenicity iso/hyper/hypo
Vascular pattern

The value of thyroid ultrasound examination
The value of thyroid ultrasound examination is as follows:
1. To detect FTL;
2. To differentiate between benign and malignant
FTL;
3. To evaluate cervical lymphadenopathy;
4. To guide interventions, e.g., biopsy and percutaneous treatment;
5. To assess change in size of thyroid nodules with
follow up US.
In all patients with palpable thyroid nodules, US
should be performed to accomplish the following [3]:
1. Detect US features suggestive of malignant growth
and select the lesions to be recommended for fineneedle aspiration (FNA);
2. Look for coincidental thyroid nodules;
3. Help with the diagnosis in difficult cases (as in
Hashimoto’s thyroiditis);
4. Choose the gauge and length of the biopsy needle;
5. Obtain an objective measure of the baseline volume and characteristics of the lesions that will be
assigned to follow-up or medical or minimally invasive therapy – Radiofrequency ablation (RFA),
Microwave ablation (MWA), Laser.
Indications for thyroid US, following the American
Association of Clinical Endocrinologists (AACE) are as
follows [8]:
1. To confirm presence of a thyroid nodule when
physical examination is equivocal.
2. To characterize a thyroid nodule(s), i.e. to measure
the dimensions accurately and to identify internal
structure and vascularization.
3. To differentiate between benign and malignant
thyroid masses, based on their sonographic appearance.
4. To differentiate between thyroid nodules and other
cervical masses like lymphadenopathy, thyroglossal cyst and cystic hygroma.
5. To evaluate diffuse changes in thyroid parenchyma.
6. To detect post-operative residual or recurrent tumor
in thyroid bed or metastases to neck lymph nodes.
7. To screen high-risk patients for thyroid malignancy like patients with history of familial thyroid
cancer, MEN type II and irradiated neck in childhood.
8. To guide diagnostic (FNA cytology/biopsy) and
therapeutic interventional procedures.
TIRADS (thyroid imaging reporting and data
system) – Classification
In the last few years, assessment concepts called as
‘grading system’ or ‘reporting system’ have emerged. In
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Table II. TIRADS classification [9].
Category
Definition

1
Normal thyroid gland

2
Benign

3
Probably
benign

Number of suspicious features

a way similar to BIRADS (Breast Imaging-Reporting
and Data System) these systems were named “Thyroid Imaging Reporting and Data System” or TIRADS.
Thyroid nodules were classified into categories related to
their US patterns and indications for FNA were based on
these categories calculating a qualitative risk [9]. However, these systems are time consuming, somewhat cumbersome and interobserver agreement is reported to be
quite low [10]. For this reason subsequent studies tried to
simplify the systems.
In 2011, Kwak et al developed a practical TIRADS
with which to categorize thyroid nodules and stratify
their malignant risk. The following US features showed
a significant association with malignancy: solid component, hypoechogenicity, marked hypoechogenicity, microlobulated or irregular margins, microcalcifications,
and taller-than-wide shape [11].
When reporting a thyroid ultrasound, some general
rules should be fulfilled:
1. Describe sonographic appearance of the thyroid
gland and structural, shape and size alterations as
shown above.
2. Describe the imaging characteristics of the nodule
as shown in table I.
3. Identify the nodule at risk to be malignant by
risk stratification based on identification of high
risk factors [12].
4. The proposed risk stratification system based
on solidity and echogenicity will be useful for risk
stratification and management decision of thyroid
nodules [13].
5. Additional evaluation of the nodule with elastography can be performed, if available.
Clinical work up
In the clinical work up of thyroid nodules, there are
some main questions should be asked:
1. Is the nodule suspicious for malignancy?
2. Is there a history of MEN II, previous neck radiation or thyroid resection?
3. Are cervical lymph nodes involved?
4. Is there a primary focus in the thyroid gland in a
patient with cervical adenopathy?
5. Is there a post-operative residual or recurrent tumor in
the thyroid bed or metastases to neck lymph nodes?

4
Suspicious for malignancy
4a
4b
4c
One
Two
3-4

5
Probably malignant

6
Biopsy proven
malignancy

All 5

Fig 1. Normal thyroid gland. Transverse ultrasound through the neck shows that the normal
thyroid consists of two lobes and a bridging
isthmus with a homogenous appearance on ultrasound.

In case of a positive answer to any of the above
questions, FNA must be performed. Recommendations
for FNA of thyroid nodules based on US features were
published by the American Thyroid Association (ATA)
in 2015 [2].
The TIRADS classification is shown in Table II [9].
Normal size, shape, echogenicity
The normal thyroid gland consists of two lobes and
a bridging isthmus. Thyroid size, shape, and volume
vary with age and sex. The normal thyroid gland (fig 1)
weighs approximately 30 g but the size and shape vary
according to age [14].
When the gland enlarges, it may extend inferiorly
into the superior mediastinum and is then described as a
retrosternal thyroid. The volume of the thyroid gland is
quite important for clinical practice since it identifies the
enlargement of the thyroid gland (goiter) and its response
to suppressive therapy. For the treatment of Graves’ disease it allows a rigorous calculation of the appropriate
radio-iodine dose. Diminution of the thyroid volume
(thyroid atrophy) can be detected in some cases, but has
less clinical importance. Normal thyroid lobe dimensions
are: 18-20 mm longitudinal and 8-9 mm antero-posterior
(AP) diameter in newborn; 25 mm longitudinal and 1215 mm AP diameter at one year age; and 40-60 mm longitudinal and 13-18 mm AP diameter in adult population.
Measurement of the thyroid lobe involves three measurements: the width, depth and length, then the volume
is calculated by the formula V = W x D x L x 0.523 (Vvolume, W-width, D-depth, L-length). The total volume

81

82

Manjiri Dighe et al

Thyroid Ultrasound: State of the Art

Fig 2. Thyroid lobe, transverse image through
the left lobe – note the relationships of the
surrounding structures: sternocleidomastoid
(SCM) and strap muscles (SM) anteriorly; trachea (Tr)/esophagus (Eso) and longus colli muscles (LCM) posteriorly; and common carotid
arteries (CA) and jugular veins (JV) bilaterally.

Fig 3. Ectopic thyroid – 24 year old with a known ectopic
thyroid with a growing mass at the base of the tongue – note
absence of the normal thyroid gland in the neck seen on transverse image through the neck (a) and presence of a hypoechoic
rounded mass (P) in the base of the tongue (A). This mass was
biopsied and was consistent with a benign adenoma.

results from the sum of the two volumes; the isthmus is
omitted, unless its thickness is over 3 mm. The limits of
normal thyroid volume are 10-15 ml for females and 1218 ml for males. The width and depth are measured on
transverse section of the lobe: the width is the distance
between the most lateral point of the lobe and the acoustic shadowing of the trachea and the depth is the maximum antero-posterior distance in the middle third of the
lobe (fig 2) [15].
In some cases, on the upper margin of the isthmus
there is an accessory lobe (Lalouette pyramid), which
must be identified and measured, and the volume must be
added to that of the lobes [16].
The structure of the thyroid gland is granulated
(ground glass appearance) and the echogenicity is similar
to that of the parotid glands, and of increased echogenicity compared to that of the adjacent muscles [15]. The relationships with surrounding structures are: sternocleidomastoid and strap muscles anteriorly; trachea/esophagus
and longus colli muscles posteriorly; and common carotid arteries and jugular veins bilaterally (fig 2) [17,18].

thyroid tissue most commonly appears in the midline in
the cervical region (90 % of the cases) [24]. Appearance
varies on US, but the tissue is generally located close to
the hyoid bone (fig 3) [20]. Its prevalence is approximately 1/100,000 – 1/300,000 [25].
Tips and tricks: Scintigraphy is more sensitive than
US for detecting an ectopic thyroid. Scintigraphy provides functional information of the thyroid which is not
available based on ultrasound examination alone. The
thyroid gland appears normal on US in patients with hypoplasia; however, scintigraphy reveals decreased isotope uptake [20].

Congenital anomalies
Congenital agenesis or hypoplasia of the thyroid
gland may include the whole gland or just one of the lobes
[19]. Congenital hypothyroidism is a relatively common
endocrine disorder [20]. Approximately 80% of congenital hypothyroidism is caused by thyroid dysgenesis due
to absence, hypoplasia or ectopia of the gland, which is
almost always sporadic in nature [21]. Ectopic thyroid
tissue is derived from incomplete migration of thyroid
gland and can be found anywhere along the migration
course of the thyroid primordium [22] which is between
the base of tongue and pretracheal region. The most common presentation is a euthyroid neck mass [23]. Ectopic

Diffuse thyroid disease (DTD)
A wide spectrum of DTDs affect the thyroid gland
with the most common being autoimmune thyroid disease (AITD). Hashimoto’s thyroiditis and Graves’ disease are the most common AITDs. US is not generally
required for the diagnosis of DTD and diagnosis is based
on presenting symptoms, laboratory analysis of thyroid
function, immunology, and occasionally radioactive iodine uptake scans [26]. Radioiodine scans are neither
needed nor recommended to diagnose Hashimoto or
Graves’ disease. In some cases, like Hashimoto’s thyroiditis, the disease is primarily subclinical and US is
helpful in detecting these patients. In addition, US helps
exclude focal thyroid disease in these patients and in assessing the size of the thyroid gland.
Ultrasonography findings indicative of DTD are characterized by a diffusely enlarged or normal size thyroid
gland or small size in later stages of DTD, decreased or
increased diffuse heterogeneous parenchymal echogenicity, a coarse echotexture, and micronodulation [27,28].
In theory, differentiation with ultrasound elastography is feasible because of the different pathologic fea-

Med Ultrason 2017; 19(1): 79-93

tures and stiffness. Yang et al in their study found that
the strain ratio (SR) values (calculated by comparing the
strain in the thyroid nodule to the sternocleiodomastoid
muscle in the same image) ranked in ascending order,
control group < hyperthyroidism group < Hashimoto’s
thyroiditis group < subacute thyroiditis group with statistically significant difference (p<0.05) between groups
and that it is feasible to assess diffuse thyroid disease
with strain ratios obtained with ultrasound elastography
[29]. In clinical practice, elastography is usually not used
for these indications.
Goiter, Struma diffusa
Generalized enlargement of the thyroid is called
goiter and can be diffuse or nodular. It may be within
a range from simple diffuse nontoxic non-nodular thyroid enlargement to multinodular goiter in a euthyroid
patient. The cause of simple goiter is multifactorial and
involves complex interactions between environmental
(iodine intake), genetic, and endogenous (female gender) factors [30]. Insufficient thyroid hormone input is
the most frequent cause worldwide except for the United States; it begins as reaction with follicular epithelium
compensatory hypertrophy which generates ordinary,
polyclonal follicles alternating with scarring caused by
hemorrhagic necrosis over the course of goiter growth
in an attempt to maintain a euthyroid state [31,32]. At
conventional B-mode US and CDI multinodular goiter
frequently appears as thyroid enlargement with focal
or diffuse replacement of the thyroid parenchyma by
strictly adjacent, sometimes, not distinctive, variable
echo structure nodules containing variable amount of
cystic degeneration, vascularization and dystrophic calcifications, without or with minimal normal remaining
parenchyma (fig 4). In the case of multiple sonographically similar appearing nodules, representative nodules,
or nodule clusters when involvement is focal, can be
identified for measurement to obtain more reproducible
follow-up [33]. The main aim of ultrasound is to iden-

Fig 4. Multinodular goiter. A 43 year old patient with multinodular goiter and hypothyroidism. Sagittal ultrasound the right lobe showed
an enlarged thyroid gland with multiple iso- to
hyperechoic nodules of variable size, however
similar in appearance.

tify nodules that have malignant sonographic features
(see TIRADS) to be submitted to ultrasound-guided
FNA [34].
Elastography
To date, no specific papers, neither specific recommendation, to the best of our knowledge have been published focusing on diffuse goiter. For the specific features
regarding single nodules please see below.
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowledge have been published focusing on diffuse goiter. For
the specific features regarding single nodules please see
below.
Tips and tricks
Thyroid scintigraphy is often used in cases where
the cause of the hyperthyroidism is unclear and to evaluate for thyroid nodules before treatment [35]. Society
of Radiologists in Ultrasound [36] recommend that sonographic features of individual nodules in a multinodular gland should be the primary criteria for suggesting biopsy rather than using nodule size. In their recent
guidelines published in 2015 ATA [2] recommends that
patients with multiple nodules >1cm should be evaluated in the same fashion as patients with a solitary nodule
>1cm with each nodule >1cm carrying an independent
risk of malignancy. If multiple nodules >1cm are present, those with a suspicious sonographic pattern should
be aspirated preferentially and if none of the nodules
have a high or moderately suspicious sonographic pattern, nodules greater than 2 cm should be aspirated
and the rest should undergo follow up with serial US
examinations [2]. The ATA guidelines use size criteria
not since there is an increased risk of cancer in larger
nodules but because lesions with different size have different prognosis.
Thyroiditis
Different causes of thyroiditis have been identified
including: infection, autoimmune processes, medication,
and ionizing radiation. As a result of the inflammatory
process, temporary or permanent impairment of thyroid
function usually follows. The different forms of thyroiditis may be clearly distinguished on the basis of clinical
findings, a few laboratory values, and the ultrasound results [37]. US guided FNA with cytological examination
is rarely needed. Scintigraphy of the thyroid is usually of
no added diagnostic value. Impairment of thyroid function is divided into hyper- and hypothyroidism [38].
The commonest types of thyroiditis encountered are
Hashimoto’s thyroiditis and de Quervain’s thyroiditis.
This section will restrict itself to discussion of these two
conditions in addition to a discussion of Graves’ disease
[39].
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Fig 5. Hashimoto’s thyroiditis – transverse scan through the
neck shows a heterogeneous thyroid gland with multiple hypoechoic areas in it on the Bode image (a) and increased vascularity on the Color Doppler (b) image.

Fig 6. Hashimoto’s thyroiditis with fibrosis –
Sagittal image through the right lobe shows a
hypoechoic thyroid lobe with multiple echogenic linear strands in it which are consistent
with fibrosis.

a) Hashimoto’s thyroiditis or Chronic Lymphocytic
thyroiditis
Hashimoto’s thyroiditis or chronic lymphocytic thyroiditis (CLT) is the most common form of organ-specific
autoimmune diseases [20]. It is the commonest cause of
hypothyroidism in the United States [27]. Its annual incidence is estimated to be between 0.3 and 1.5 cases per 1000
persons, with no significant race-related predominance
[27]. Hashimoto’s thyroiditis affects 1.3% of children and
has a female predominance [40], with a 8 to 9:1 female
to male ratio [41]. The disease usually develops in young
or middle aged women and leads to progressive thyroid
failure [42]. It is characterized by diffuse interstitial lymphocytic infiltration and a variable degree of fibrosis [43].
Diagnosis is made by detecting anti-thyroid antibodies,
including anti-thyroid peroxidase and anti-thyroglobulin
antibodies [20]. Patients with the acute form present with
painless, lobular, diffusely enlarged thyroid gland (classical Hashimoto´s) or – much more common – an atrophic
thyroid (historically named as Ord´s thyroiditis) [27].
Conventional B-mode ultrasound
Hashimoto’s thyroiditis is primarily a subclinical disease, and US can detect this subset of patients before they
come to clinical attention when typical US findings are
present [44].
US is useful for measuring thyroid size and assessing
echotexture. Sonographic appearances vary depending on

Thyroid Ultrasound: State of the Art

Fig 7. Vascularity in thyroiditis can be variable depending on
the stage of the disease. a) Sagittal US image through the right
lobe shows a heterogeneous gland with hypervascularity in it on
color Doppler which is due to early stage in this patient. b) Different patient with known chronic thyroiditis shows a decreased
vascularity likely due to the atrophic stage in this patient.

the degree of gland involvement, which include severity of
follicular disruption, lymphocytic infiltration, and chronicity of disease and extent of thyroid involvement. Initially
the parenchyma is heterogeneous and coarsened compared
with normal thyroid (fig 5). In some patients, innumerable
hypoechoic solid micro nodules are seen ranging in size
from 1 to 7 mm surrounded by echogenic rim of fibrosis.
This appearance is highly specific with a positive predictive value of 95% [28]. As the disease progresses, thyroid parenchyma is progressively destroyed and develops
echogenic linear bands of parenchymal fibrosis which can
become confluent and thicker (fig 6). There can be asymmetric involvement with preference for the anterior part
of the gland. Eventually the gland becomes atrophic with
a hypoechoic appearance similar to that of strap muscles.
Color Doppler imaging (CDI)
CDI in Hashimoto’s is variable with either normal
or increased vascularity seen in the early disease. The
increase in vascularity seems to be associated with development of hypothyroidism [45]. Later in the disease
course, the gland shows decreased vascularity.
On CDI, the hypertrophic form (Hashimoto’s thyroiditis) presents itself with slightly increased vascularity
(hyperthyroid phase) in the early stages (fig 7a), whereas
the stage of atrophy is characterized by reduced or absent
vascularization (fig 7b). During the phase of clinically
manifest hypothyroidism, vascularization may increase
once more. Peak systolic velocity (PSV) in the afferent
arteries is normal in all stages (slightly increased in the
case of manifest hypothyroidism), thereby facilitating the
differentiation from Graves’ disease [38].
Elastography
Sporea et al reported a cut-off value >2.53 m/s using
shear wave elastography (SWE) for differentiation between normal thyroid and diffuse thyroid diseases, with
a positive predictive value >90% [46]. They also found
a statistically significant difference in velocity values in
autoimmune pathology with a value of 2.07±0.44 m/s in
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Graves’ disease compared with 2.68±0.50 m/s in chronic
autoimmune thyroiditis [47].
Kim et al found a cut-off mean value of the EI (elasticity index) using carotid artery as the internal compression source, in cases of diffuse thyroid disease, of 27.6
kPa and a maximum value of 41.3 kPa, with a sensitivity of 40.9% and a specificity of 82.9% [48]. Magri et
al studied the EI in patients with chronic autoimmune
thyroiditis and found that the elasticity of extra nodular
tissue is decreased according to the thyroid antibody titer
and the degree of thyroid function damage [49].
Fukuhara et al evaluated the utility of Acoustic Radiation Force Impulse (ARFI) SWE for diagnosing chronic
autoimmune thyroiditis (CAT) and to verify the effect
of fibrotic thyroid tissue on SWV. The SWV for CAT
(2.47±0.57m/s) was significantly higher than that for controls healthy subjects (1.59±0.41 m/s) (p<0.001). AUROC
for CAT was 0.899, and the SWV cut-off value was 1.96
m/s. The sensitivity, specificity, and diagnostic accuracy
were 87.4%, 78.7%, and 85.1%, respectively. Levels of anti-thyroperoxidase antibodies and thyroid isthmus thickness
were correlated with tissue stiffness in CAT. However, there
was no correlation between levels of anti-thyroglobulin antibodies and tissue stiffness. Quantitative SWE is useful for
diagnosing CAT, and it is possible that SWE can be used to
evaluate the degree of fibrosis in patients with CAT [50].
Magri et al indicated that SWE correctly defines the
elasticity of thyroid nodules independently from the coexistence of autoimmune thyroiditis, always being able
to differentiate nodular tissue from the surrounding parenchyma. In Hashimoto’s thyroiditis the stiffness of extra-nodular tissue increases in relation to both the thyroid
antibody titer and the degree of impairment of thyroid
function [49]. For a cut-off value of 22.3 kPa, which resulted in the highest sum of sensitivity and specificity,
the EI assessed by SWE had a sensitivity of 59.6% and
a specificity of 76.9% (AUROC=0.71; p<0.001) for predicting the presence of autoimmune thyroid disease [51].
However, in clinical practice, elastography is usually
not needed for these indications.
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowledge have been published focusing on Hashimoto’s thyroiditis. For the specific features regarding single nodules
please see below.
Tips and tricks
US guided FNA is an appropriate means of establishing tissue diagnosis and should be used in association
with appropriate laboratory studies, FNA, demonstrating
diffuse lymphocytic infiltration, as well as high-titer antibodies against thyroid peroxidase (anti-TPO) (sensitivity
70-90%) might be helpful in the diagnostics of chronic

Fig 8. Graves’ disease – 30 year old female
with known Graves’ disease. Sagittal US
through the right lobe shows an enlarged gland
with a heterogeneous appearance.

Hashimoto’s thyroiditis in the early stages. The atrophic
form is characterized by an elevated basal TSH level and
requires no further laboratory tests or cytological diagnostics. Scintigraphy (mottled accumulation pattern and
low nuclide uptake) provides no additional information
[38].
b) Graves’ disease
Hyperthyroidism is rare in childhood and is most
commonly caused by Graves’ disease. It affects 0.02 %
of children or 1 in 5000 [40]. The peak incidence occurs
from 11-15 years of age with a female predominance. A
positive family history is common. Graves’ disease is an
autoimmune disorder that results in hyper-functioning of
the thyroid. It is caused by thyroid receptor antibodies
binding to the thyrotropin receptor (TSH-receptor). The
typical biochemical thyrotoxic profile is matched by a
diffuse enlargement of the thyroid gland with rounding
of the normal angular outline [52].
Conventional B-mode ultrasound
No specific findings are present, however findings
suggestive of the disease include diffuse enlargement,
convex bowing of the anterior gland margin and mild
textural coarsening (fig 8). The echogenicity is often
decreased due to the increased blood flow, increased
cellularity and decreased colloid content. Compared to
Hashimoto’s thyroiditis, the appearance of the thyroid in
Graves’ disease is less heterogeneous and the contour is
lobulated [53]. Features of increased volume, hypervascularity, and heterogeneous reduced echogenicity have
been shown in Graves’ disease [35].
Color Doppler imaging
Normal thyroid parenchyma shows occasional spots
of flow on color Doppler; peak systolic velocities between
15 and 30 cm/s in the inferior thyroid artery and 3 to 5
cm/s in the intrathyroid arteries are considered within the
range of normal [54]. Increased vascularity and arteriovenous shunting is called “thyroid inferno” which is suggestive of Graves’ disease (fig 9). Studies have shown that
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Fig 9. Thyroid inferno. A 44 year old female
with known Graves’ disease. Sagittal US
through the left lobe shows a significantly hypervascular gland with the appearance suggesting an inferno hence called as “thyroid inferno”.

color and spectral Doppler interrogation can differentiate
Graves’ disease from other causes of hyperthyroidism
with high specificity [54]. Patients with untreated, active
Graves’ disease show markedly increased vascularity at
color Doppler. Thyroid blood flow (TBF) can present
clearer information of minute blood flow than traditional
power Doppler mode and is calculated as an advanced dynamic flow/region of interest (ADF/ROI) ratio by special
software. ADF is a recently developed high-resolution
power Doppler mode used as a quantitative method for
calculating TBF. TBF was significantly higher (p<0.0001)
in Graves’ disease than in painless thyroiditis, subacute
thyroiditis, or normal controls. The TBF of patients with
Graves’ disease was consistently >4%, and all other patients had TBF <4%, indicating that 4% is the cutoff for
distinguishing destruction-induced thyrotoxicosis and
Graves’ disease [55]. Patients with Graves’ disease show
an approximately 15-fold higher TBF measured in mL/
min compared with normal and high peak systolic velocity flow on spectral Doppler in the medium-sized perithyroid and intra-thyroid a rteries [56].
English et al described the typical sonographic features
of the thyroid gland in patients with Graves’ hyperthyroidism after radioiodine therapy (RIT). The sonographic
features of the post-RIT gland included a significantly
reduced mean total volume of 4.2 mL, hypovascularity,
coarse echotexture, and hyperechogenicity [35]. Currently, thyroid imaging does not play a routine role in the
post-treatment follow-up of RIT patients, but thyroid ultrasound would be employed if there was a change in the
size (enlargement) or nodularity of a treated gland [35].
Elastography
Sporea et al found that thyroid stiffness (TS) assessed
by means of ARFI SWE in healthy subjects (2±0.40
m/s) was significantly lower than in Graves’ disease
(2.67±0.53 m/s) (p<0.0001) and CAT patients (2.43±0.58
m/s) (p=0.0002), but the differences were not significant
between Graves’ disease and CAT patients (p=0.053).
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The optimal cut-off value for the prediction of diffuse
thyroid pathology was 2.36 m/s. For this cut-off value,
TS had 62.5% sensitivity, 79.5% specificity, 87.6% predictive positive value, 55.5% negative predictive value,
and 72.7% accuracy for the presence of diffuse thyroid
gland pathology (AUROC=0.804). There were no significant differences between the TS values obtained with
linear vs convex probes and when 5 vs 10 measurements
were taken in each lobe (median values). ARFI SWE
seems to be a useful method for the evaluation of diffuse
thyroid gland pathology and is able to predict with sufficient accuracy the presence of diffuse thyroid diseases
(AUROC=0.80) [46,47].
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowledge have been published focusing on Graves’ disease.
Tips and tricks
Thyroid scintigraphy is often used in cases where the
cause of the hyperthyroidism is unclear and to evaluate
thyroid nodules before treatment [35].
c) Subacute granulomatous thyroiditis
(De Quervain or granulomatous thyroiditis)
The clinical scenario differs in that the patient presents with a painful swelling in the lower neck, fever, and
sometimes lethargy; typically following a viral illness.
Typically no hyperthyroidism is observed. The biochemistry in the acute phase might appear as thyroid toxicity, sometimes followed by a period of hypothyroidism.
Typically (after a period of 6 – 18 months from acute
onset) the patient recovers and becomes euthyroid. Subacute granulomatous thyroiditis (SGT) is a self-limiting
subacute inflammatory disease of the thyroid [57]. It typically occurs in the area of the gland in mid-aged hyperthyroid women complaining of pain, tenderness, fatigue
and mild fever [58] and constitutes nearly 3-6% of all
thyroid diseases. Generally appears 2 weeks after a viral
upper respiratory tract infection and regresses spontaneously within 2-3 months. Although its etiology remains
unknown, it is believed have a viral origin, similar to the
mumps virus, hepatitis B and C viruses, cytomegalovirus, enterovirus, and type A and B coxsackie viruses.
Clinically, patients present with localized anterior neck
pain associated with glandular tenderness and diffuse
pain in the ears and the jaw, which might be accompanied by fatigue, weight loss, low-grade fever, elevated CReactive Protein (CRP), elevated erythrocyte sedimentation rate, suppression in the TSH level and occasionally
dysphagia [59].
Conventional B-mode ultrasound
Characteristic US findings include ill-defined, moderately or markedly patchy hypoechoic areas in the thyroid.
Hypoechoic areas tend to elongate along the long axis of

Med Ultrason 2017; 19(1): 79-93

Fig 10. Subacute granulomatous thyroiditis. A
32 year old male with subacute granulomatous
thyroiditis. Transverse US image through the
right lobe shows patchy hypoechoic areas (arrowheads) in the thyroid gland which did not
conform to nodules on the sagittal image.

the thyroid. In severe disease, the capsule can be expanded in the affected regions [60]. Generally, an increase in
the size of the thyroid and heterogeneous, diffuse, hypoechoic and confluent areas with negative margins, characteristically defined as “lava flow,” are observed on US
(fig 10) [59,61,62]. Hypoechoic appearance can also be
seen in malignancy, however other features like calcifications and taller than wide shape are absent. Short-term
follow up is useful to document regression or resolution.
In addition, a prompt clinical response to anti-inflammatory therapy is highly diagnostic.
In the acute phase, US can detect a hypoechoic illdefined mass, usually tender. The adjacent thyroid tissue is heterogeneous in echotexture. In the subacute
phase, the hypoechoic area increases in size to involve
the ipsilateral thyroid lobe and sometimes extends to the
contralateral lobe. And during recovery phase, thyroid
appearances returns to normal or atrophy may develop
[62]. Typically, enlarged and activated lymph nodes can
be found on US as well.
Color Doppler imaging
No increase in vascularity occurs at CDI. However,
these findings are nonspecific because they may also be
seen in CLT, multinodular goiter, and Graves’ diseases,
and the clinical findings may assist in the differential diagnosis [59,62].
On CDI, the hypoechoic lesions show reduced or absent vascularity, whereas the remaining thyroid displays
normal vascularity. Peak systolic velocity of the afferent
arteries is typically normal [63].
The sonographic changes described above are no
longer demonstrable after complete remission of the disease.
Elastography
Stiff areas are seen in the thyroid gland in SGT and
these stiff areas can be stiffer comparing with chronic
thyroiditis, resembling malignant nodules on elastogra-

Fig 11. A 38 year old female with cytology
proven subacute granulomatous thyroiditis.
Elastography with ARFI showed a very hard
thyroid gland with stiffness measurement
of >8 m/s.

phy (fig 11) [64,65]. Xie et al found that real-time strain
US elastography does not provide conclusive information in the diagnosis and differential diagnosis of SGT
due to its inability to distinguish between this pathology
and thyroid cancer [64].
Yang et al found that the SR (mean±standard deviation) (calculated by using the sternocleidomastoid muscle
on the same side of the thyroid as the reference tissue) of
patients with hyperthyroidism, Hashimoto’s thyroiditis,
and SGT were 2.30±1.08, 7.04±7.74, and 24.09±13.56,
respectively. The SR of the control group was 1.76±0.54.
SR values ranked in ascending order were control group,
hyperthyroidism group, Hashimoto’s thyroiditis group,
SGT group. There were statistically significant (p<0.05)
differences in thyroid hardness between groups with different diffuse thyroid diseases [29].
Thyroid tissue stiffness was higher in SGT at baseline
(214.26±32.5 kPa) in comparison with values recorded
at a 4-week follow-up (45.92±17.4 kPa) and at 10 weeks
following diagnosis and treatment initiation (21.65±5.3
kPa, p<0.0001). Baseline thyroid stiffness in SGT was
higher than in CAT (36.15±18.7 kPa, p<0.0001) and
healthy control subjects (16.18±5.4 kPa, p<0.0001). In
the remission of SGT, thyroid stiffness was lower than
that found in CAT (p=0.006), and higher comparing with
healthy control subjects (p=0.0008) [66].
Subacute inflammatory pseudonodules were found
to have greater stiffness comparing with nodules found
in chronic thyroiditis, and in this condition, elastography
could be unable to detect thyroid cancer [66].
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowledge have been published focusing on subacute granulomatous thyroiditis.
Tips and tricks
SGT may be diagnosed conclusively by B mode
ultrasound in 90% of cases if the clinical picture is
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typical. Rarely, other thyroid diseases with hypoechoic
echo texture must be considered, and CDI contributes
with important additional information towards the differential diagnosis. Complementary US guided FNA,
demonstrating giant cells and histiocytes, confirms the
diagnosis and may be helpful in unclear cases. Scintigraphy, as in other cases of thyroid inflammation, does not
contribute any additional information and should not be
performed [38].
d) Riedel struma
Riedel’s struma (fibrosing thyroiditis) is an extremely
rare, local manifestation of a systemic form of fibrosclerosis. Most patients with Riedel’s thyroiditis (RT) are between 30 and 50 years old at the time of diagnosis [67]. It
is a rare inflammatory disease that results in fibrosis of the
thyroid gland and invasion to the surrounding structures
of the neck [68]. Although the etiology of RT is unclear,
the most probable cause is an autoimmune process [69].
The condition is associated with extensive fibrosis in the
gland that spreads to the neighboring tissues and is associated with the presence of inflammatory cell infiltrates.
It is characterized by an increasingly massive fibrous alteration of the thyroid and the surrounding tissues, resulting in indolent hard swelling of the neck [70]. RT is
more common in females, with an operative incidence of
0.06% reported. The disease is frequently associated with
fibrosis of the mediastinum and retroperitoneum, similar
to IgG4-mediated disease such as Ormond’s disease [71].
Conventional B-mode ultrasound
US shows an enlarged, hypoechoic gland or with a
coarsened echotexture with fibrous septations resulting
in pseudonodular appearance (fig 12a) [72]. Perithyroid
extension is present [73-75].
Color Doppler imaging
Previously published CDI features of RT include a
decrease in vascular flow [76], or only slight vascularization of the mass (fig 12 b) [73]. The US vascular en-

Fig 12. Riedels Thyroiditis. B mode image showing a heterogeneous thyroid parenchyma with macro calcifications. There
is no discrete nodule and the entire gland is involved. The linear
echogenic ‘streaks’ represent fibrotic bands. Vascularity was
mainly peripheral, whereas centrally it is reduced
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casement and improvement with corticosteroid treatment
clearly appear to be specific to RT [75].
Elastography
Elastography showed heterogeneity in the stiffness
values of the thyroid parenchyma varying between 21
kPa and 281 kPa. USE revealed heterogeneity in the stiffness values of the thyroid parenchyma. It should be noted
that the hypoechoic areas corresponded to the highest
stiffness values. These areas could correspond to a high
degree of fibrosis. Longer follow-up times are necessary
to evaluate the extent to which corticosteroid treatment
can alter such stiffness values [75].
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowledge have been published focusing on RT.
Tips and tricks
Currently, there are no well-established cytomorphologic criteria published in the literature in RT [77].
e) Post partum thyroiditis
Post-partum thyroiditis (PPT) is a special form of autoimmune thyroiditis, which occurs in the first year after parturition. PPT is characterized by transient hyperthyroidism
followed by transient hypothyroidism during the first six
postpartum months. It is seen in 5-9% of women and recurred in 75% of cases in subsequent pregnancies, often
being not recognized because the symptoms of hyperthyroidism (1-3 months post partum) and of slight hypothyroidism (4-10 months post partum) are misinterpreted as
puerperal depression or as a [78]. The disease is self-limiting, and thyroid function commonly returns to normal after one year; permanent hypothyroidism is rare. Diagnosis
is based upon clinical manifestations and thyroid function
tests (TSH and free T4). Assessment of anti-TPO antibodies may also help in the diagnosis and thyrotropin receptor
antibodies (TRAB) should be negative [79].
Conventional B-mode ultrasound
Typically the gland appears hypoechoic either diffuse
or with multifocal areas of low echogenicity scattered
throughout both lobes of the thyroid resulting in a heterogenous appearance [80].
Color Doppler imaging
In comparison to Graves’ disease, there is no ‘vascular inferno’. In older studies, blood flow is reported
to be mostly reduced and increased vascularity is rare.
Peak systolic velocity is normal [38]. However, depending on US-devices used, an increased blood flow can be
detected very similar to that seen in the acute phase of
Hashimoto´s disease.
Elastography
To date, no specific papers, to the best of our knowledge have been published focusing on postpartum thyroiditis.
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Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowledge have been published focusing on postpartum thyroiditis.
Tips and tricks
Scintigraphy does not have any role in diagnosis or
follow up of patients with PPT, especially since the postpartum patients might be breastfeeding her child, which
is a contraindication to radioiodine administration. Neither is biopsy recommended in these patients, unless a
concomitant focal lesion is seen.
f) Silent thyroiditis
Silent thyroiditis is a rare painless disease. Slight hypothyroidism is clinically apparent, seldom followed by
hypothyroidism. Anti-TPO antibodies are often low and
only temporarily present. The disease shows spontaneous
remission within a few months [81].
Conventional B-mode ultrasound
Sonographic findings equal post-partum thyroiditis
[82].
Color Doppler imaging
No specific information has been listed in the literature in regards to CDI in silent thyroiditis. From personal
experience it can be reported that an increased blood
flow can be detected very similar to that seen in the acute
phase of Hashimoto´s or postpartum thyroiditis.
Elastography
To date, no specific papers, to the best of our knowledge have been published focusing on silent thyroiditis.
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowledge have been published focusing on silent thyroiditis.
Tips and tricks
Because silent thyroiditis might show US features
very similar to other forms of hyperthyroidism, a radioscan can be helpful in differentiating silent thyroiditis
from TRAB negative Graves’ disease or a diffuse autonomy. Scintigraphy during the hyperthyroid phase of thyroiditis would show low values for radioiodine uptake,
usually less than 1% compared with high values seen in
Graves’ disease. This can help in differentiating between
the two diseases [83].
g) Varia: Amiodaron and interferon induced
thyroid disease
Amiodarone is a potent iodine-rich drug; however,
side effects on the thyroid and other organs may counterbalance its beneficial effects on the heart. It can cause
isolated abnormalities of thyroid function tests and overt
thyroid dysfunction, either hypothyroidism (amiodarone-induced hypothyroidism [AIH]) or thyrotoxicosis
(amiodarone-induced thyrotoxicosis [AIT] [84]). It may
develop early on or after many years of amiodarone treat-

ment, sometimes following drug withdrawal due to prolonged tissue storage of iodinated amiodarone metabolites [85].
AIH occurs more frequently than AIT in iodine-sufficient areas. In contrast to AIT, AIH is more frequent in
females with a female to male ratio of 1.5:1 [86]. AIH
patients are also older than AIT with circulating thyroid
autoantibodies seen in almost 53% of AIH patients with
underlying thyroid abnormalities especially Hashimoto’s
thyroiditis [87].
Males are more frequently affected by AIT (M/F ratio
3:1). Incidence has been reported to range between 1%
and 23% [88]. 15-20% of patients on amiodarone treatment develop either AIT or hypothyroidism. Two types
of AIT are present; type 1 is a form of iodine-induced
hyperthyroidism that develops in abnormal glands (multinodular goiter or latent Graves’ disease). The thyrotoxicosis in this type is caused by excessive thyroid hormone
synthesis and is treated with anti-thyroid drugs. The more
common type 2 AIT occurs in patients without underlying thyroid disease. Thyrotoxicosis in these patients is
caused by amiodarone-induced destructive thyroiditis;
the disease is treated with steroids [89].
In addition, thyroid disease is a common side effect
of interferon-based antiviral therapy for chronic hepatitis C, which may lead to dose reduction or discontinuation of therapy. The two entities observed are destructive forms of thyroiditis as well as INF-induced Graves’
disease [90].
Conventional B-mode ultrasound
In patients with AIT type 1, US shows a diffuse or
nodular goiter (fig 13), while in patients with AIT type 2,
ultrasound shows a normal or small diffuse goiter. USfindings of IFN-induced thyroid disease are similar to the
entities observed without IFN.
Color Doppler imaging
CDI has been shown to be a useful tool in differentiating type 1 AIT from type 2. Using a classification that
subdivides CDI features into four patterns (0–III), some

Fig 13. A 69 year old male patient with known cardiac disease
being treated with Amiodarone. Patient had initially hyperthyroidism and hence was sent for a thyroid US which showed an
echogenic appearing thyroid lobe with no nodules.
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authors have reported that CDI showed mild to markedly
increased flow in the thyroid in patients with AIT type 1,
whereas flow within the thyroid is markedly decreased
or absent in patients with AIT type 2 [91-93]. Moreover,
the analysis of nodular and extranodular blood flow was
useful in the definition of the underlying thyroid diseases
in type 1 AIT, being able to differentiate toxic multinodular goiter and toxic adenoma from Graves’ disease [91].
This differentiation appeared to be of clinical relevance
regarding therapeutic choice and outcome [94,95]. Separate evaluation of parenchymal blood flow from that of
nodules may prove beneficial in the diagnosis of underlying thyroid diseases in patients with type 1 AIT [91].
In IFN-induced thyroid disease, a reduction in echogenicity suggestive for a destructive process of the thyroid gland was observed on US even before changes in
thyroid function of antibody status could be measured.
Risk factors for the development of thyroid dysfunction
were age, female gender, pre-treatment thyroid volume,
pre-existing thyroglobulin/thyroid peroxidase antibodies
and viral load. Power-Doppler ultrasound could reliably
differentiate between destructive thyroiditis and Graves’
disease [90].
Elastography
To date, no specific papers, to the best of our knowledge have been published focusing on Amiodarone induced thyrotoxicosis
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowledge have been published focusing on Amiodarone induced thyrotoxicosis
Tips and tricks
Scintigraphy can differentiate between the two forms
of AIT with positive scans seen in AIT 1 and negligible
uptake seen in AIT II [96].
h) Acute thyroiditis
Acute thyroiditis is a very rare disease, predominantly occurring in immuno-suppressed patients. It may develop locally or hematogenically in septicemia. The classical symptoms of a florid inflammation with fever, sore
throat, painful swelling, reddening of the skin and lymph
node enlargement can be found [38]. Acute suppurative
thyroiditis is uncommon due to the excellent lymphatic
drainage, encapsulation, and high iodine content in the
gland. It usually affects children and young adults with
congenital fourth branchial pouch sinus tracts [27].
Conventional B-mode ultrasound
Conventional US scan depicts ill-defined thyroid
borders, the echo texture is inhomogeneous; hypoechoic
and anechoic areas represent colliquation. In most cases,
lymph nodes with inflammatory changes may be demonstrated [38]. US findings are nonspecific and the gland

may appear enlarged and hypoechoic due to inflammation. Focal fluid collection with bright echoes in it from
gas can suggest an abscess [48].
Color Doppler imaging
May show normal or increased blood flow.
Elastography
To date, no specific papers, to the best of our knowledge have been published focusing on acute thyroiditis
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowledge have been published focusing on acute thyroiditis
Tips and tricks
FNA confirms the diagnosis by identifying the causative pathogen. If clinical and sonographic findings are
inconclusive, other forms of thyroiditis or malignant tumor might have to be excluded by cytological examination. Acute thyroiditis may usually be cured by antibiotic therapy. In advanced stages with abscess formation,
local drainage or even surgery might become necessary
[38,97].
Conclusion
A wide spectrum of DTD’s affect the thyroid gland
and US is not generally required for the diagnosis of
DTD. In some cases, like Hashimoto’s thyroiditis, US
helps exclude focal thyroid disease in these patients and
in assessing the size of the thyroid gland. US contrast
and elastography is in its infancy and larger studies are
needed to evaluate the utility of these new techniques
in diffuse thyroid diseases. We also refer to the recently
published World Federation in Ultrasound and Medicine
(WFUMB) thyroid elastography guidelines [98].
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